Iterum Therapeutics plc (ITRMF) Change in Cash (2017 - 2025)

Iterum Therapeutics has reported Change in Cash for 9 years, with the latest figure at -$2.0 million in Q3 2025.

• On a quarterly basis, Change in Cash fell 124.07% year-over-year to -$2.0 million in Q3 2025; TTM through Sep 2025 was -$2.4 million, a 128.04% decrease from a year earlier, with the FY2024 full-year figure at $18.1 million, up 220.19% from the prior year.
• Change in Cash was -$2.0 million for Q3 2025 at Iterum Therapeutics, down from $374000.0 in the prior quarter.
• The five-year high for Change in Cash was $51.9 million in Q1 2021, with the low at -$30.1 million in Q2 2021.
• Average Change in Cash over 5 years is -$199210.5, with a median of -$621000.0 recorded in 2021.
• The sharpest annual moves came in 2022 and 2025: Change in Cash soared 1916.43% in 2022, then slumped 970.49% in 2025.
• Over 5 years, Change in Cash stood at -$8.5 million in 2021, then surged by 106.71% to $573000.0 in 2022, then surged by 119.02% to $1.3 million in 2023, then jumped by 754.1% to $10.7 million in 2024, then plunged by 118.93% to -$2.0 million in 2025.
• The last three Change in Cash figures came in at -$2.0 million (Q3 2025), $374000.0 (Q2 2025), and -$11.5 million (Q1 2025), per Business Quant data.